0R9T Stock Overview
Equasens Société anonyme provides healthcare IT solutions in Europe.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 2/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 0R9T from our risk checks.
Equasens Société anonyme Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €58.00 |
52 Week High | €85.60 |
52 Week Low | €46.50 |
Beta | 0.94 |
1 Month Change | 13.06% |
3 Month Change | 8.41% |
1 Year Change | -19.11% |
3 Year Change | -41.59% |
5 Year Change | 3.02% |
Change since IPO | 216.25% |
Recent News & Updates
Recent updates
Shareholder Returns
0R9T | GB Healthcare Services | GB Market | |
---|---|---|---|
7D | -0.2% | -2.5% | 2.8% |
1Y | -19.1% | 35.9% | 1.1% |
Return vs Industry: 0R9T underperformed the UK Healthcare Services industry which returned 35.9% over the past year.
Return vs Market: 0R9T underperformed the UK Market which returned 1.1% over the past year.
Price Volatility
0R9T volatility | |
---|---|
0R9T Average Weekly Movement | 4.9% |
Healthcare Services Industry Average Movement | 8.3% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0R9T has not had significant price volatility in the past 3 months.
Volatility Over Time: 0R9T's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 1,200 | Denis Supplisson | equasens.com |
Equasens Société anonyme provides healthcare IT solutions in Europe. It offers id. PATIENT, a business software; id.
Equasens Société anonyme Fundamentals Summary
0R9T fundamental statistics | |
---|---|
Market cap | €871.93m |
Earnings (TTM) | €48.50m |
Revenue (TTM) | €223.12m |
18.0x
P/E Ratio3.9x
P/S RatioIs 0R9T overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0R9T income statement (TTM) | |
---|---|
Revenue | €223.12m |
Cost of Revenue | €150.32m |
Gross Profit | €72.81m |
Other Expenses | €24.31m |
Earnings | €48.50m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Sep 27, 2024
Earnings per share (EPS) | 3.23 |
Gross Margin | 32.63% |
Net Profit Margin | 21.74% |
Debt/Equity Ratio | 28.9% |
How did 0R9T perform over the long term?
See historical performance and comparison